A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
Lim SG, Ng TM, Kung N, Krastev Z, Volfova M, Husa P, Lee SS, Chan S, Shiffman ML, Washington MK, Rigney A, Anderson J, Mondou E, Snow A, Sorbel J, Guan R, Rousseau F; Emtricitabine FTCB-301 Study Group.
Lim SG, et al. Among authors: rousseau f.
Arch Intern Med. 2006 Jan 9;166(1):49-56. doi: 10.1001/archinte.166.1.49.
Arch Intern Med. 2006.
PMID: 16401810
Clinical Trial.